Steven H. Bernstein

Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells

Yohei Iwata, Takashi Matsushita, Mayuka Horikawa et al. · Blood · 2010 · 1.1K citations · Full text

Life Sciences, Cell Biology, Immunology +12

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Richard I. Fisher, Steven H. Bernstein, Brad S. Kahl et al. · Journal of Clinical Oncology · 2006 · 708 citations

Medicine, Hematology, Oncology +15

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

André Goy, Steven H. Bernstein, Brad S. Kahl et al. · Annals of Oncology · 2008 · 340 citations · Full text

Medicine, Hematology, Oncology +13

Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516—The Southwest Oncology Group

Steven H. Bernstein, Joseph M. Unger, Michael LeBlanc et al. · Journal of Clinical Oncology · 2008 · 233 citations · Full text

Medicine, Oncology, Chemotherapy +14

Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas

Jonathan W. Friedberg, Daruka Mahadevan, Erin Cebula et al. · Journal of Clinical Oncology · 2013 · 209 citations · Full text

Medicine, Hematology, Pharmacology +17